Returning guest, Dr. Adriana Carrillo-Iregui, pediatric endocrinologist within the Division of Pediatric Endocrinology at Nicklaus Children’s Hospital discusses immunotherapy for at risk children that is an emerging treatment for Type 1 diabetes. She explains how it works and which pediatric patients are candidates for this drug.
Dr. Carrillo-Iregui is a pediatric endocrinologist within the Division of Pediatric Endocrinology at Nicklaus Children’s Hospital. Dr. Carrillo-Iregui received her medical degree at the Universidad El Bosque in Bogota, Colombia and completed a pediatric residency at Nicklaus Children’s Hospital followed by a fellowship in pediatric endocrinology at the University of Miami, Jackson Memorial Hospital. She is board certified in pediatrics and pediatric endocrinology. Before joining Nicklaus Children’s she was an Assistant Professor of Pediatrics in the Division of Pediatric Endocrinology at the University of Miami, Miller School of Medicine. Her research and clinical interest has focused on metabolic disorders related to obesity, polycystic ovarian syndrome and type 2 diabetes. She has published extensively and lectured nationally and internationally.